• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Introduction to 1-Pentyn-3-ol, 3-ethyl-1-phenyl- (CAS No. 73830-10-1) and Its Emerging Applications in Chemical Biology

The compound 1-Pentyn-3-ol, 3-ethyl-1-phenyl- (CAS No. 73830-10-1) represents a fascinating molecule with a unique structural framework that has garnered significant attention in the field of chemical biology and pharmaceutical research. This alkyne derivative, characterized by its pentynyl and ethylphenyl substituents, exhibits intriguing chemical properties that make it a valuable scaffold for the development of novel bioactive molecules. The precise arrangement of functional groups in this compound not only influences its reactivity but also opens up diverse possibilities for its application in synthetic chemistry, drug design, and mechanistic studies.

At the heart of the compound's appeal lies its dual functionality—the presence of both a terminal alkyne group and an ethyl-substituted phenyl ring. The terminal alkyne (C≡C) moiety is particularly noteworthy, as it serves as an excellent handle for various chemical transformations, including cross-coupling reactions such as Sonogashira coupling and Buchwald-Hartwig amination. These reactions are pivotal in constructing complex molecular architectures, which are often required in the synthesis of biologically active compounds. Additionally, the phenyl ring introduces electronic and steric effects that can modulate the compound's interactions with biological targets.

In recent years, the study of 1-Pentyn-3-ol, 3-ethyl-1-phenyl- has been extended to explore its potential in medicinal chemistry. Researchers have leveraged its structural features to develop novel scaffolds for small-molecule drugs. For instance, the alkyne group has been utilized to introduce pharmacophoric elements that enhance binding affinity to specific biological receptors. This approach has led to the discovery of compounds with promising activities in areas such as anti-inflammatory and anticancer therapy. The ethylphenyl moiety, on the other hand, contributes to the molecule's solubility and metabolic stability, making it an attractive candidate for further development.

The compound's versatility is further highlighted by its role as an intermediate in the synthesis of more complex molecules. For example, it has been employed in the preparation of macrocyclic compounds that mimic natural products with potent biological activities. These macrocycles often exhibit high selectivity for their targets due to their precisely tuned steric and electronic properties. The ability to modify both the alkyne and phenyl components allows chemists to fine-tune these properties, leading to optimized pharmacological profiles.

Advances in computational chemistry have also played a crucial role in understanding the behavior of 1-Pentyn-3-ol, 3-ethyl-1-phenyl-. Molecular modeling studies have provided insights into how its structure influences its interactions with biological targets at the atomic level. These insights are invaluable for guiding drug design efforts, as they allow researchers to predict and optimize binding affinities before conducting costly experimental trials. Additionally, computational methods have been used to explore potential degradation pathways of this compound, ensuring that synthetic routes are both efficient and sustainable.

The synthesis of 1-Pentyn-3-ol, 3-ethyl-1-phenyl-* has been refined over time through various methodologies that highlight its adaptability as a synthetic intermediate. One notable method involves the palladium-catalyzed coupling of propargyl bromide with phenylethanolamine derivatives under mild conditions. This approach offers high yields and excellent regioselectivity, making it a preferred choice for industrial-scale production. Alternatively, transition-metal-free coupling strategies have also been explored, particularly when dealing with sensitive functional groups that might be incompatible with palladium catalysts.

The compound's applications extend beyond pharmaceuticals into materials science and agrochemicals. Its unique structure makes it a suitable candidate for developing novel polymers with tailored properties. For instance, polymers incorporating alkyne units can be functionalized through click chemistry techniques to create materials with enhanced mechanical strength or biodegradability. In agrochemicals, derivatives of 1-Pentyn-* 3-*ol, 3-*ethyl-* 1-*phenyl-* have shown promise as intermediates for herbicides and fungicides due to their ability to interact selectively with biological targets in plants.

Recent research has also explored the potential of 1-Pentyn-* 3-*ol, 3-*ethyl-* 1-*phenyl-* as a tool in chemical biology for studying enzyme mechanisms and protein-protein interactions. Its ability to undergo selective modifications allows researchers to label or probe biological systems without significant perturbation. This has opened up new avenues for understanding complex biological processes at a molecular level.

The future prospects for 1-Pentyn-* 3-*ol, 3-*ethyl-* 1-*phenyl-* are promising as new synthetic methodologies continue to emerge and our understanding of its reactivity deepens. Continued exploration of its applications in drug discovery is likely to yield novel therapeutics targeting previously unaddressed disease mechanisms. Furthermore, interdisciplinary approaches combining organic chemistry with bioinformatics will enhance our ability to design molecules with optimized properties.

• 154954-75-3(Cyclohexanol, 2-methyl-1-(phenylethynyl)-, cis- (9CI))
• 24580-49-2(Cyclohexanol, 2-methyl-1-(phenylethynyl)-)
• 1966-65-0(1-Pentyn-3-ol,3-methyl-1-phenyl-)
• 89458-21-9(1-Pentyn-3-ol, 3,4-dimethyl-1-phenyl-)
• 19781-33-0(1-Phenyl-3-ethyl-1-heptyn-3-ol)
• 20109-09-5(1-(Phenylethynyl)-1-cyclohexanol)
• 25118-60-9(Cyclopentanol,1-(2-phenylethynyl)-)
• 155204-17-4(1-Hexyn-3-ol, 3,5-dimethyl-1-phenyl-)
• 154954-76-4(Cyclohexanol, 2-methyl-1-(phenylethynyl)-, trans- (9CI))
• 24580-61-8(Cyclohexanol, 4-methyl-1-(phenylethynyl)-)